Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Octreotide: inhibits gastric hypersecretion but does not affect parietal cell mass in Zollinger-Ellison syndrome

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Octreotide: inhibits gastric hypersecretion but does not affect parietal cell mass in Zollinger-Ellison syndrome. Inpharma Wkly. 530, 5 (1986). https://doi.org/10.1007/BF03299014

    Download citation

    Keywords

    • Ranitidine
    • Octreotide
    • Subcutaneous Injection
    • Parietal Cell
    • Acid Output